C07J 41/00

Technology



back to "C07J 41/00" profile

More Results

Showing 1 to 20 of 305 results

Patent/Pub #TitleFiling DateIssue/Publication DatePatent Owner
RE49949 Reducing risk of contracting clostridium-difficile associated diseaseJan 09, 20Apr 30, 24The Board of Regents of the Nevada System of Higher Education on Behalf of the University of Nevada, Las Vegas
RE49233 Ionizable cationic lipid for RNA deliveryMar 12, 19Oct 04, 22Arcturus Therapeutics, Inc.
RE48286 Steroids as agonists for FXRJun 21, 19Oct 27, 20Intercept Pharmaceuticals Inc.
RE46955 Sulfated oligosaccharide derivativesSep 09, 16Jul 17, 18Progen PG500 Series Pty Ltd
9993563 Compounds and methods for trans-membrane delivery of moleculesJul 28, 16Jun 12, 18Aposense Ltd.
9982009 Methods for treating polycystic kidney disease and polycystic liver diseaseOct 15, 14May 29, 18Massachusetts Institute of Technology; Yale University;
9968554 Modified drugs for use in liposomal nanoparticlesJun 12, 14May 15, 18The University of British Columbia
9938315 Chemical compounds and use thereof for improving muscular qualityMay 20, 15Apr 10, 18INSTITUT BIOPHYTIS SAS; UNIVERSITÉ PARIS 6 PIERRE ET MARIE CURIE;
9931419 Methods and compositions for liposomal formulation of antigens and uses thereofJun 13, 16Apr 03, 18Molecular Express, Inc.; The Regents of the University of California;
9904167 Compound, active light sensitive or radiation sensitive resin composition, resist film using same, resist-coated mask blank, photomask, pattern forming method, method for manufacturing electronic device, and electronic deviceDec 29, 15Feb 27, 18FUJIFILM CORPORATION
9889202 Compounds and methods for trans-membrane delivery of moleculesOct 01, 15Feb 13, 18APOSENSE LTD.
9884066 Bile acid-basic amino acid conjugates and uses thereofJun 05, 14Feb 06, 18YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM
9868757 5-β, 14-β-androstane derivatives useful for the treatment of proteinuria, glomerulosclerosis and renal failureNov 03, 15Jan 16, 18CVIE THERAPEUTICS LIMITED
9862744 Reducing risk of contracting clostridium-difficile associated diseaseJul 13, 15Jan 09, 18BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION, ON BEHALF OF THE UNIVERSITY OF NEVADA, RENO
9850273 Combination of estrogens plus antiprogestins with significant partial agonistic effect as an effective treatment of menopausal symptoms and for prevention of the occurrence of breast cancerDec 03, 15Dec 26, 17EVESTRA, INC.
9834578 Enhanced sensitivity for analysis of ketosteroid compounds using mass spectrometryMay 24, 11Dec 05, 17UNIVERSITY OF UTAH
9814735 Certain chemical entities, compositions, and methodsJun 20, 16Nov 14, 17SUZHOU NEUPHARMA CO., LTD.
9802978 Progesterone phosphate analogs and uses related theretoAug 11, 14Oct 31, 17EMORY UNIVERSITY
9796668 Natural product analogs including an anti-inflammatory cyanoenone pharmacore and methods of useNov 24, 15Oct 24, 17REATA PHARMACEUTICALS, INC.
9790253 OSW-1 analogs and conjugates, and uses thereofMay 18, 12Oct 17, 17PRESIDENT AND FELLOWS OF HARVARD COLLEGE

Showing 1 to 20 of 305 results